Advertisement
Advertisement
U.S. markets open in 2 hours 53 minutes
Advertisement
Advertisement
Advertisement
Advertisement

NuGen Medical Devices Inc. (NGMDF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.09000.0000 (0.00%)
At close: 09:32AM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.0900
Open0.0900
BidN/A x N/A
AskN/A x N/A
Day's Range0.0900 - 0.0900
52 Week Range0.0700 - 0.2200
Volume10,000
Avg. Volume3,309
Market Cap7.843M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-0.0760
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for NGMDF

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
    View more
    • ACCESSWIRE

      NuGen M.D. Commences Trading on OTCQB Under The Symbol 'NGMDF'

      NuGen Medical Devices Inc. (TSXV:NGMD)(OTCQB:NGMDF) ("NuGen'' or the "Company"), a leader in needle-free drug delivery, is pleased to announce that, effective July 27, 2022, its common shares will commence trading on the OTCQB under the symbol NGMDF.

    • ACCESSWIRE

      NuGen Announces Offering and Closing of First Tranche of Private Placement

      NuGen Medical Devices Inc. (TSXV:NGMD) (the "Company") announces that it has closed the first tranche of a non-brokered private placement through the issuance of 4,118,000 units ("Units") at a price of $0.10 per Unit for gross proceeds of $411,800 (the "Offering"). Each Unit is comprised of one common share ("Common Share") of the Company and one Common Share purchase warrant ("Warrant").

    • ACCESSWIRE

      NuGen M.D. Receives Additional Health Canada Approval for Insulin Specific Needle-Free Injection System

      NuGen Medical Devices Inc. (TSXV:NGMD) ("NuGen'' or the "Company"), a leader in needle-free drug delivery, is pleased to announce that its needle-free injection system and accessories, also known as InsuJet™, has been approved by Health Canada specifically for the needle-free delivery of insulin.

    Advertisement
    Advertisement